Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Clinical trial NCT04158076 · COMPLETED
Trial details
- NCT number
- NCT04158076
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2021-01-14
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.